Physitrack (OSTO:PTRK) Cash And Cash Equivalents : kr8.3 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Physitrack Cash And Cash Equivalents?

Physitrack's quarterly cash and cash equivalents declined from Jun. 2024 (kr6.42 Mil) to Sep. 2024 (kr5.93 Mil) but then increased from Sep. 2024 (kr5.93 Mil) to Dec. 2024 (kr8.32 Mil).

Physitrack's annual cash and cash equivalents declined from Dec. 2022 (kr6.35 Mil) to Dec. 2023 (kr6.00 Mil) but then increased from Dec. 2023 (kr6.00 Mil) to Dec. 2024 (kr8.32 Mil).

Physitrack Cash And Cash Equivalents Historical Data

The historical data trend for Physitrack's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Physitrack Cash And Cash Equivalents Chart

Physitrack Annual Data

Trend

Nov18

Nov19

Nov20

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.13

12.83

6.35

6.00

8.32

Physitrack Quarterly Data
	Nov18	Nov19	Feb20	Aug20	Nov20	Feb21	Jun21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial															6.00	6.68	6.42	5.93	8.32

Physitrack Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Physitrack (OSTO:PTRK) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Physitrack Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Physitrack's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Physitrack Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Physitrack PLC (OSTO:PTRK) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

140 London Wall, Bastion House 6th Floor, London, GBR, EC2Y 5DN

Website

https://www.physitrack.com

Physitrack PLC is a digital healthcare provider, focused on B2B physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World.

Physitrack Headlines

No Headlines